Synthesis and screening of DNA-encoded Libraries of Non-Peptidic Macrocycles
Synthesis and screening of DNA-encoded Libraries of Non-Peptidic Macrocycles
批准号:
10323626
负责人:
Eric Koesema
金额:
$73.4万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-08-31
关键词:
Active SitesAddressAffinityAldehydesAmidesAminesAreaBiotechnologyCellsCharacteristicsChemicalsChemistryCollectionCommunicable DiseasesComplexDNADevelopmentDiseaseDiversity LibraryDrug TargetingEnzymesExplosionGenerationsHumanImmunoglobulin GIndustryKnowledgeLeadLibrariesLigandsMalignant NeoplasmsMedicalMethodsModelingNucleic AcidsPeptidesPermeabilityPharmaceutical PreparationsPhasePlant ResinsPlayPositioning AttributeProteinsProteomePublicationsReactionResearch ContractsRoleSolventsSourceStreptavidinStructureSurfaceTP53 geneTestingTherapeuticWorkanalogdesigndrug qualityinhibitor/antagonistinnovationnovelpathogenprotein protein interactionscaffoldscreeningsuccessthioethertranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Most drugs target proteins with relatively deep pockets, such as enzyme active sites. However, screening
collections comprised of these traditional Rule of 5-compliant molecules have consistently failed to provide high
quality drug leads for many targets that function via protein-nucleic acid and protein-protein interactions (PPIs).
These are the “difficult” or “undruggable” protein targets, which by some estimates comprise up to 85% of the
human proteome. The importance of these types of PPIs has been well noted in cancer therapeutics and more
recently in the infectious diseases field where PPIs play a role in the interaction between host and pathogen.
Macrocyclic peptides (MPs) are capable of engaging these shallow, solvent exposed surfaces, but most MPs are
not cell permeable. This highlights the critical need for the development of libraries of novel, cell permeable
compounds capable of engaging PPI surfaces. In Phase I, we successfully demonstrated the feasibility of
generating and screening large DNA-encoded libraries of non-peptidic macrocycles, which have the appropriate
characteristics to address this need. In this Phase II project, we will expand the chemical diversity of these
libraries, test them against several difficult targets, and establish methods to evolve primary screening hits
derived from the libraries into high-quality drug leads.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金